Oncotelic Therapeutics
(OTCQB:OTLC)
$0.038
0[0.00%]
Last update: 1:00PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Oncotelic Therapeutics Stock (OTC:OTLC), Quotes and News Summary

Oncotelic Therapeutics Stock (OTC: OTLC) stock price, news, charts, stock research, profile.

Open$0.038
Close-
Volume / Avg.2.501K / 75.104K
Day Range0.038 - 0.038
52 Wk Range0.010 - 0.053
Market Cap$15.188M
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1

Recent News

Sponsored
Oncotelic Therapeutics' (OTCQB: OTLC) Lead Immunotherapy Candidate For Treating Deadly Cancers, OT-101, Could Hold Potential Applications In Multiple Multi-Billion Dollar Markets
Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company. Its primary focus is on developing innovative drugs for oncology and infectious disease and aging.
Sponsored
With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company.
Sponsored
The Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB:OTLC) Is Leading The Charge
Solid tumors are abnormal clumps of cells that form in various tissues or organs of the body. Unlike liquid or cystic tumors, solid tumors do not contain any liquid components. They can occur in bones, muscles and organs, and can be either benign or malignant.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Oncotelic Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing d...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
OTLC

FAQ

Q

How do I buy Oncotelic Therapeutics (OTLC) stock?

A

You can purchase shares of Oncotelic Therapeutics (OTCQB: OTLC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Oncotelic Therapeutics's (OTLC) competitors?

A

There are no as such competitors for Oncotelic Therapeutics.

Q

What is the target price for Oncotelic Therapeutics (OTLC) stock?

A

There is no analysis for Oncotelic Therapeutics.

Q

Current Stock Price for Oncotelic Therapeutics (OTLC)?

A

The stock price for Oncotelic Therapeutics (OTCQB: OTLC) is $0.0351 last updated October 10, 2023 at 9:25 AM EDT.

Q

Does Oncotelic Therapeutics (OTLC) pay a dividend?

A

There are no upcoming dividends for Oncotelic Therapeutics.

Q

When is Oncotelic Therapeutics (OTCQB:OTLC) reporting earnings?

A

Oncotelic Therapeutics does not have any upcoming earnings scheduled.

Q

Is Oncotelic Therapeutics (OTLC) going to split?

A

There is no upcoming split for Oncotelic Therapeutics.

Q

What sector and industry does Oncotelic Therapeutics (OTLC) operate in?

A

Oncotelic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.